Clinical Trial Update: Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants [Phase 4]

View source ↗

Summary

A Phase 4 trial reports that the absence of residual vein thrombosis permits withdrawal of oral anticoagulants in patients with deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Snippet

Sponsor: Azienda Ospedaliera Universitaria Policlinico | Conditions: Deep Vein Thrombosis | Phase 4 | Status: COMPLETED